体外膜肺氧合成功治疗新型冠状病毒肺炎诱发的急性呼吸窘迫综合征并随访1年：1例病例报告
Successful management of COVID-19 induced acute respiratory distress syndrome by extracorporeal membrane oxygenation with 1-year follow-up: A case report.
作者信息
Chang Ko-Wei, Lee Kuang-Tso, Lo Yu-Lun, Hu Han-Chung, Yang Cheng-Ta, Lin Shu-Min
机构信息
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan.
Department of Cardiovascular, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan.
出版信息
IDCases. 2021;26:e01281. doi: 10.1016/j.idcr.2021.e01281. Epub 2021 Sep 3.
Coronavirus 2019 (referred to as COVID-19) has infected millions of people throughout the world. This paper reports on a case of COVID-19-induced acute respiratory distress syndrome (ARDS) in which the patient was administered extracorporeal membrane oxygenation (ECMO) to deal with refractory hypoxia. The patient recovered from ARDS following ECMO treatment. In 1-year follow-up, the muscle weakness persisted, and the pulmonary vital capacity recovered sooner than diffusion capacity.
2019冠状病毒病（简称COVID-19）已在全球感染了数百万人。本文报告了一例由COVID-19引起的急性呼吸窘迫综合征（ARDS），该患者接受了体外膜肺氧合（ECMO）治疗以应对难治性低氧血症。患者在接受ECMO治疗后从ARDS中康复。在1年的随访中，肌无力持续存在，肺肺活量比弥散能力恢复得更快。
Zotero 插件